Citi sees shares of Ligand Pharmaceuticals soaring another 46% on top of an already impressive year-to-date rally.
Category: Uncategorized
Walmart’s move to Nasdaq is part of a wider plan to build an AI and e-commerce powerhouse, investors say
One potential reason for Walmart’s move to the tech-heavy Nasdaq is to justify a higher valuation, investor Kevin Simpson told CNBC.
Nvidia gets the OK from Trump to sell chips to China. Is it a reason to buy the stock?
There’s enough in Nvidia’s green light from the Trump administration to sell chips in China to add to Wall Street’s confidence in the stock.
There’s no Dow or S&P 500 for cryptocurrencies yet. Bitwise is getting a step closer with new ETF
The move comes despite a series of recent pullbacks in the crypto market that saw bitcoin trade at around $85,000 earlier this month.
Why Netflix is making a big mistake trying to buy Warner Bros. Discovery, according to a top analyst
Laura Martin of Needham estimates that buying WBD would put $83 billion of additional value at risk of disruption from generative AI.
Disney’s chart is pointing to a rebound. How to capture a trading profit using options
Nishant Pant describes why the charts are signaling the Disney comeback has more room to run.
Traders brace for a ‘hawkish cut’ from the Fed. Here’s what that means
Wall Street expects the Fed to deliver a “hawkish cut” this week. Not sure what that means? Well, wonder no more.
Deutsche Bank sees more upside for Micron heading into chipmaker’s earnings
Deutsche Bank’s revised price target implies additional upside of 13% ahead for shares of Micron.
A little-known biotech stock more than doubled this week. Why Wells Fargo sees further upside
The bank reiterated the Singapore-based biotech name as overweight and hiked its price target.
This cruise stock is outperforming. Goldman Sachs expects momentum to carry into 2026
The bank upgraded the cruise stock to buy from neutral.